E-LIB Suche - Ergebnisse für: Belderbos, Robert

1

Dendritic cells loaded with allogeneic tumour cell lysate p..:

Aerts, Joachim G ; Belderbos, Robert ; Baas, Paul...
The Lancet Oncology. 25 (2024) 7 - p. 865-878 , 2024

2

OX40 agonism enhances PD-L1 checkpoint blockade by shifting..:

van der Sluis, Tetje C. ; Beyrend, Guillaume ; van der Gracht, Esmé T.I....
Cell Reports Medicine. 4 (2023) 3 - p. 100939 , 2023

Link: https://doi.org/10.1016/..

3

Incidence, treatment and survival of malignant pleural and ..:

van Kooten, Job P ; Belderbos, Robert A ; von der Thüsen, Jan H...
Thorax. 77 (2022) 12 - p. 1260-1267 , 2022

Link: https://doi.org/10.1136/..

4

High-intensity statins are associated with improved clinica..:

Cantini, Luca ; Pecci, Federica ; Hurkmans, Daan P....
European Journal of Cancer. 144 (2021) - p. 41-48 , 2021

Link: https://doi.org/10.1016/..

5

Ki67 (MIB-1) as a Prognostic Marker for Clinical Decision M..:

Belderbos, Robert A. ; Maat, Alexander P.W.M. ; Baart, Sara J....
JTO Clinical and Research Reports. 2 (2021) 4 - p. 100155 , 2021

Link: https://doi.org/10.1016/..

6

In Response to "Intratumor Distribution of Ki-67 Antigen Be..:

Belderbos, Robert A. ; Aerts, Joachim G.J. V. ; von der Thüsen, Jan H.
JTO Clinical and Research Reports. 2 (2021) 9 - p. 100215 , 2021

Link: https://doi.org/10.1016/..

7

Cellular Immunotherapy and Locoregional Administration of C..:

Belderbos, Robert A. ; Vroman, Heleen ; Aerts, Joachim G. J. V.
Frontiers in Oncology. 10 (2020) - p. , 2020

Link: https://doi.org/10.3389/..

8

T cell receptor repertoire characteristics both before and ..:

Vroman, Heleen ; Balzaretti, Giulia ; Belderbos, Robert A...
Journal for ImmunoTherapy of Cancer. 8 (2020) 1 - p. e000251 , 2020

Link: https://doi.org/10.1136/..

9

Enhancing Dendritic Cell Therapy in Solid Tumors with Immun..:

Belderbos, Robert A. ; Aerts, Joachim G.J.V. ; Vroman, Heleen
Molecular Therapy - Oncolytics. 13 (2019) - p. 67-81 , 2019

Link: https://doi.org/10.1016/..

10

OX40 agonism enhances PD-L1 checkpoint blockade by shifting..:

van der Sluis, Tetje C ; Beyrend, Guillaume ; van der Gracht, Esmé T.I...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040386/. , 2023

Link: http://www.ncbi.nlm.nih...

11

Incidence, treatment and survival of malignant pleural and ..:

van Kooten, Job P ; Belderbos, Robert A ; von der Thüsen, Jan H...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685713/. , 2022

Link: http://www.ncbi.nlm.nih...

12

Ki67 (MIB-1) as a Prognostic Marker for Clinical Decision M..:

Belderbos, Robert A ; Maat, Alexander P.W.M ; Baart, Sara J...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474452/. , 2021

Link: http://www.ncbi.nlm.nih...

13

Ki67 (MIB-1) as a Prognostic Marker for Clinical Decision M..:

Belderbos, Robert A ; Maat, Alexander P.W.M ; Baart, Sara J...
Belderbos , R A , Maat , A P W M , Baart , S J , Madsen , E V E , Bogers , A J J C , Cornelissen , R , Aerts , J G J V , Mahtab , E A F & von der Thüsen , J H 2021 , ' Ki67 (MIB-1) as a Prognostic Marker for Clinical Decision Making Before Extended Pleurectomy Decortication in Malignant Pleural Mesothelioma ' , JTO Clinical and Research Reports , vol. 2 , no. 4 , 100155 . https://doi.org/10.1016/j.jtocrr.2021.100155. , 2021

Link: https://pure.eur.nl/en/p..

14

In Response to "Intratumor Distribution of Ki-67 Antigen Be..:

Belderbos, Robert A ; Aerts, Joachim G.J.V ; von der Thüsen, Jan H
Belderbos , R A , Aerts , J G J V & von der Thüsen , J H 2021 , ' In Response to "Intratumor Distribution of Ki-67 Antigen Beyond Labeling Index for Clinical Decision Making : A New Way of Counting" ' , JTO Clinical and Research Reports , vol. 2 , no. 9 , 100215 . https://doi.org/10.1016/j.jtocrr.2021.100215. , 2021

Link: https://pure.eur.nl/en/p..

15

In Response to "Intratumor Distribution of Ki-67 Antigen Be..:

Belderbos, Robert A ; Aerts, Joachim G.J. V ; von der Thüsen, Jan H
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486919/. , 2021

Link: http://www.ncbi.nlm.nih...